Your browser is no longer supported. Please, upgrade your browser.
Settings
WST West Pharmaceutical Services, Inc. daily Stock Chart
WST [NYSE]
West Pharmaceutical Services, Inc.
IndexS&P 500 P/E71.26 EPS (ttm)3.78 Insider Own0.60% Shs Outstand73.80M Perf Week-2.96%
Market Cap19.70B Forward P/E57.59 EPS next Y4.68 Insider Trans-7.64% Shs Float73.41M Perf Month-1.68%
Income285.70M PEG4.75 EPS next Q1.00 Inst Own95.10% Short Float1.01% Perf Quarter21.16%
Sales1.95B P/S10.13 EPS this Y18.20% Inst Trans2.24% Short Ratio1.38 Perf Half Y91.03%
Book/sh21.77 P/B12.38 EPS next Y10.90% ROA12.50% Target Price265.00 Perf Year88.32%
Cash/sh6.10 P/C44.18 EPS next 5Y15.00% ROE18.60% 52W Range124.53 - 288.65 Perf YTD79.28%
Dividend0.64 P/FCF83.94 EPS past 5Y12.90% ROI13.00% 52W High-6.63% Beta1.13
Dividend %0.24% Quick Ratio2.20 Sales past 5Y5.30% Gross Margin34.10% 52W Low116.42% ATR8.32
Employees8200 Current Ratio3.00 Sales Q/Q12.20% Oper. Margin17.30% RSI (14)46.73 Volatility3.06% 3.28%
OptionableYes Debt/Eq0.16 EPS Q/Q37.20% Profit Margin14.70% Rel Volume0.77 Prev Close263.64
ShortableYes LT Debt/Eq0.16 EarningsJul 23 BMO Payout16.30% Avg Volume538.41K Price269.51
Recom1.70 SMA20-1.91% SMA50-0.35% SMA20034.75% Volume413,652 Change2.23%
Jul-21-20Upgrade BofA Securities Neutral → Buy $280
Apr-24-20Upgrade BofA/Merrill Underperform → Neutral $145 → $200
Dec-12-19Downgrade BofA/Merrill Neutral → Underperform
Jul-26-19Upgrade BofA/Merrill Underperform → Neutral
May-01-19Downgrade Jefferies Buy → Hold $122
Apr-23-19Initiated William Blair Outperform
Apr-25-18Downgrade BofA/Merrill Neutral → Underperform
Jan-24-18Initiated Goldman Neutral
Oct-17-17Downgrade BofA/Merrill Buy → Neutral
Oct-03-17Initiated Stephens Equal-Weight
Sep-15-17Upgrade Jefferies Hold → Buy
Oct-28-16Upgrade Wells Fargo Market Perform → Outperform
Sep-21-16Downgrade Wells Fargo Outperform → Market Perform
Mar-22-16Initiated Wells Fargo Outperform
May-14-10Reiterated UBS Neutral $41 → $44
Feb-23-10Initiated Jefferies & Co Buy $45
Dec-19-08Initiated UBS Neutral $41
Dec-19-08Initiated UBS Neutral
Feb-29-08Downgrade UBS Buy → Neutral
Nov-07-07Reiterated Lehman Brothers Underweight $45 → $42
Sep-18-20 03:42PM  
10:53AM  
08:58AM  
Sep-16-20 11:30AM  
Sep-10-20 04:41PM  
Sep-04-20 11:18AM  
Sep-02-20 05:37PM  
Aug-31-20 11:30AM  
10:25AM  
Aug-27-20 10:23AM  
07:24AM  
Aug-24-20 01:12PM  
Aug-18-20 12:45PM  
Aug-14-20 11:30AM  
Aug-06-20 08:44AM  
Aug-04-20 09:24AM  
Aug-03-20 11:05AM  
Jul-31-20 12:13PM  
Jul-30-20 06:43AM  
Jul-23-20 10:32PM  
10:51AM  
07:30AM  
07:15AM  
06:00AM  
Jul-22-20 12:10PM  
Jul-20-20 11:30AM  
Jul-17-20 10:34AM  
Jul-16-20 12:32PM  
Jul-15-20 11:40AM  
07:20AM  
06:00AM  
Jul-14-20 09:15AM  
Jul-13-20 11:55AM  
Jul-12-20 08:54PM  
Jul-09-20 06:00AM  
Jul-08-20 08:41AM  
Jul-06-20 10:07AM  
09:30AM  
09:28AM  
Jul-03-20 08:00AM  
Jul-02-20 10:16AM  
08:47AM  
Jul-01-20 09:33AM  
08:35AM  
Jun-30-20 09:38AM  
09:37AM  
Jun-29-20 09:42AM  
09:41AM  
Jun-27-20 12:02PM  
Jun-25-20 11:20AM  
Jun-19-20 11:55AM  
09:13AM  
Jun-18-20 10:14AM  
09:39AM  
07:21AM  
Jun-17-20 09:16AM  
Jun-16-20 09:46AM  
Jun-15-20 10:04AM  
10:02AM  
Jun-11-20 08:09AM  
Jun-10-20 08:19AM  
Jun-09-20 09:43AM  
06:51AM  
Jun-08-20 02:29PM  
09:25AM  
08:00AM  
Jun-04-20 08:48AM  
Jun-03-20 03:13PM  
08:54AM  
Jun-02-20 12:43PM  
10:49AM  
Jun-01-20 09:50AM  
09:41AM  
May-29-20 12:11PM  
May-27-20 06:22AM  
May-21-20 06:00AM  
May-19-20 08:43AM  
08:02AM  
May-18-20 07:30PM  
11:35AM  
07:02AM  
06:59AM  
May-15-20 05:48PM  
May-14-20 12:15PM  
May-06-20 03:10PM  
Apr-30-20 01:14PM  
Apr-28-20 08:48AM  
Apr-27-20 09:15AM  
Apr-23-20 07:30AM  
07:00AM  
06:00AM  
Apr-22-20 04:18PM  
08:40AM  
Apr-20-20 06:00AM  
Apr-16-20 12:32PM  
12:08PM  
Apr-15-20 02:00PM  
Apr-10-20 12:10PM  
Apr-09-20 06:00AM  
Apr-02-20 01:52PM  
West Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, Ireland, France, Other European countries, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, and washing and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment serves pharmaceutical, diagnostic, and medical device companies. It distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. The company was founded in 1923 and is headquartered in Exton, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MONTECALVO DAVID ASVP, Glob Ops and Supply ChainJul 29Option Exercise83.475,358447,2329,582Jul 30 06:22 PM
MONTECALVO DAVID ASVP, Glob Ops and Supply ChainJul 29Sale270.703,273886,0146,309Jul 30 06:22 PM
MONTECALVO DAVID ASVP, Glob Ops and Supply ChainJul 28Option Exercise74.3313,7921,025,16818,732Jul 30 06:22 PM
MONTECALVO DAVID ASVP, Glob Ops and Supply ChainJul 28Sale264.8214,5083,842,0474,224Jul 30 06:22 PM
Abraham SiljiChief Digital & Trans OfficerMay 11Option Exercise86.241,00086,2406,894May 12 02:11 PM
Abraham SiljiChief Digital & Trans OfficerMay 11Sale204.501,000204,5005,894May 12 02:11 PM
Abraham SiljiChief Digital & Trans OfficerMay 08Option Exercise86.241,00086,2406,894May 12 02:11 PM
Abraham SiljiChief Digital & Trans OfficerMay 08Sale200.001,000200,0005,894May 12 02:11 PM
MILLER GEORGE LLOYDSr. VP, GC & Corp. Sec.May 01Sale189.381,805341,8377,540May 05 05:13 PM
Abraham SiljiChief Digital & Trans OfficerApr 28Option Exercise86.2450043,1205,041Apr 30 12:10 PM
Abraham SiljiChief Digital & Trans OfficerApr 28Sale200.66500100,3284,541Apr 30 12:10 PM
Favorite Annette FSr. VP Human Resources OfficerApr 27Option Exercise55.0914,192781,83722,401Apr 29 04:48 PM
Favorite Annette FSr. VP Human Resources OfficerApr 27Sale196.9014,1922,794,4218,209Apr 29 04:48 PM